Mexico receives shipment of 870,000 doses of COVID-19 vaccine from India

India prepares five sites for final phase human trials of Oxford-AstraZeneca vaccine

<p>Five sites across the country are ready for the third and final phase of human trials of the Oxford-AstraZeneca COVID-19 vaccine, numerous media reports claimed. The Serum Institute of India, the largest vaccine maker in the country, has been chosen by Oxford and pharma giant AstraZeneca to manufacture the vaccine once it is ready. Trials […]</p>